Posters 270Oversensing in subcutaneous implantable cardioverter-defibrillators71Early stimulation of the fast-conducting endocardium is the primary factor in reducing myocardial activation times for endocardial cardiac resynchronisation therap72The impact of age on outcomes in primary prevention icd recipients: a competing risks analysis73The effects of epicardial and endocardial pacing on the constituent waves of coronary flow: coronary resynchronisation74Manifestation of repolarisation and conduction abnormalities following exercise in concealed type 1 brugada75Delivering universal public access automated external defibrillators in the united kingdom: starting at the heart of the community76Under use of oral anticoagulation in new patients with atrial fibrillation: a clinical practice research datalink study77Complete extraction of abdominal pacing and icd leads- a unique case series78The impact of adjunctive complex fractionated atrial electrogram ablation and linear lesions on outcomes in persistent atrial fibrillation: a meta-analysis79Analysis of two novel risk calculators for the prediction of cardiac implantable electronic device infection80General anaesthesia improves the success rates of pulmonery vein isolation for paroxysmal atrial fibrillation ablation: Table 1Wilson, D.G.; Hyde, E.R.; Wilson, D.G.; Claridge, S.; Leong, K.M.W; Salciccioli, J.D.; Conroy, R.; Ganesha Babu, G.; Scott, P.A.; Manupati, S.; Lazdam, M.; Leventogiannis, G.; Barr, C.; Morgan, J.M.; Plank, G.; Rinaldi, C.A.; Niederer, S.A.; Zeljko, H.M.; Leventopoulos, G.; Ahmed, N.; Thomas, G.; Duncan, E.D.; Rodderick, P.J.; Morgan, J.M.; Chen, Z.; Jackson, T.; Behar, J.; Ali, M.; Bostock, J.; Lumley, M.; Williams, R.; Assress, K.; De Silva, K.; Gill, J.; Perera, D.; Rinaldi, C.; Ng, F.S.; Kanapeckaite, L.; Hu, M.; Roney, C.; Lim, P.B.; Harding, S.E.; Peters, N.S.; Varnava, A.; Kanagaratnam, P.; Marshall, D.C.; Sykes, M.; Lim, P.B.; Lee, S.; Rotheram, N.; Macedo, A.F.; Cobb, V.; Providencia, R.; Srinivasan, N.; Ahsan, S.; Chow, A.; Murgatroyd, F.D.; Silberbauer, J.; Hooper, J.; Zaman, M.; Yao, Z.; Zaidi, A.; Ahmed, F.Z.; Virdee, M.; Heck, P.; Agarwal, S.; Lee, J.; Grace, A.; Begley, D.; Fynn, S.P. · Europace · 2015

ORAL ABSTRACTS (3)EP & Ablation31LEFT ATRIAL POSTERIOR WALL ISOLATION (THE “BOX LESION PATTERN”) IN THE TREATMENT OF ATRIAL FIBRILLATION: A SINGLE CENTRE EXPERIENCE32DAY CASE CRYOBLATION (CRYO) FOR PAROXYSMAL ATRIAL FIBRILLATION (pAF) IN THE DISTRICT GENERAL HOSPITAL IS SAFE AND EFFECTIVE IF DONE IN HIGH VOLUME WITH EXPERIENCED OPERATORS33ABLATION INDEX-GUIDED PULMONARY VEIN ISOLATION FOR ATRIAL FIBRILLATION MAY IMPROVE CLINICAL OUTCOMES IN COMPARISON TO CONTACT FORCE-GUIDED ABLATION34THE PROCEDURAL COMPLICATION RATES AND SHORT-TERM SUCCESS RATES OF THORACOSCOPIC AF ABLATION DURING THE INSTITUTIONAL LEARNING CURVE35INITIAL PROCEDURAL RESULTS FROM DDRAMATIC-SVT STUDY: DD MECHANISM IDENTIFICATION AND LOCALISATION USING DIPOLE DENSITY MAPPING TO GUIDE ABLATION STRATEGY36MORBIDITY AND MORTALITY IN MIDDLE-AGED INDIVIDUALS WITH ATRIAL FIBRILLATION: UK BIOBANK DATAClinical EP37THE GM AHSN AF LANDSCAPE TOOL: A SHARED PUBLIC DATA PLATFORM TO PROMOTE QUALITY IMPROVEMENTS AND IDENTIFY OPPORTUNITIES TO PREVENT AF-RELATED STROKE IN THE DEVOLVED GREATER MANCHESTER HEALTH SYSTEM38REAL WORLD PERSISTENCE, ADHERENCE AND SWITCH-OVER ACROSS ANTICOAGULANTS IN ATRIAL FIBRILLATION-A NATIONAL POPULATION-BASED STUDY39ORTHOSTATIC HYPOTENSION AND ATRIAL FIBRILLATION40PREVALENCE OF SHORT QT AND CRITERIA OF SEVERITY IN A YOUNG ASYMPTOMATIC COHORT41SURFACE ELECTROCARDIOGRAPHIC FEATURES AND PREVALENCE OF ARRHYTHMIAS IN PAEDIATRIC FRIEDREICH'S ATAXIA42RISK STRATIFICATION OF TYPE 1 MYOTONIC DYSTROPHY: IS THE ECG ACCURATE ENOUGH TO SELECT PATIENTS AT RISK OF BRADYARRHYTHMIC EVENTS?Furniss, G.O.; Opel, A.; Hussein, A.; Pearman, C.M.; Grace, A.; Connelly, D.T.; Orlowski, A.; Banerjee, A.; McNicholas, T.; Providencia, Rui; Montañes, M.E.M.; Providencia, Rui; Panagopoulos, D.; Tomlinson, D.R.; Dalrymple-Hay, M.; Haywood, G.A.; Butler, A.; Ang, R.; Ullah, W.; Schwartz, R.; Fannon, M.; Finlay, M.; Hunter, R.; Schilling, R.; Das, M.; Asfour, I.; Morgan, M.; Ronayne, C.; Shaw, M.; Snowdon, R.; Gupta, D.; Todd, D.; King, R.; Hall, M.; Modi, S.; Mediratta, N.; Gupta, D.; Reddy, V.; Neuzil, P.; Willems, S.; Verma, A.; Heck, P.; Schilling, R.; Lambiase, P.; Hall, M.; Nicholl, B.I.; McQueenie, R.; Jani, B. D; McKeag, N.; Gallacher, K.; Mair, F.S.; Heaton, D.; Macdonald, J.; Burnell, J.; Ryan, R.; Marshall, T.; Sutton, C.; O'Callaghan, S.; Kenny, R.A.; Karim, N.; Srinivasan, N.; Ferreira, M.J.; Goncalves, L.; Lambiase, P.D.; Toledano, M.T.; Field, E.F.; Walsh, H.W.; Maguire, K.M.; Cervi, E.C.; Kaski, J.P.K.; Perez Tome, M.C.; Pantazis, A.; Elliott, P.; Lambiase, P.D.; Segal, O. · Europace · 2016

TREATMENT OF HYPERTENSION IN PREGNANCY: GUIDELINES AND CLINICAL EXPERIENCEGaisenok, O. V.; Zamyatina, O. A.; Denisova, N. Yu.; Leonov, A. S. · Rational Pharmacotherapy in Cardiology · 2014

HYPERTHYROIDISM AND ATRIAL FIBRILLATIONMarusenko, I. M.; Petrova, E. G. · Rational Pharmacotherapy in Cardiology · 2017

RANOLAZINE IN ISCHEMIC HEART DISEASELupanov, V. P. · Rational Pharmacotherapy in Cardiology · 2012

VERTIGO IN INTERNAL MEDICINE PRACTICEDrapkina, O. M.; Chaparkina, S. O. · Rational Pharmacotherapy in Cardiology · 2007

ANGIOTENSIN II AND MYOCARDIAL INFARCTIONShevchenko, O. P.; Shevchenko, А. О. · Rational Pharmacotherapy in Cardiology · 2008

DOBUTAMINE USAGE IN CARDIOLOGICAL PRACTICEGiljarov, M. Yu. · Rational Pharmacotherapy in Cardiology · 2008

UNIVERSAL DEFINITION OF MYOCARDIAL INFARCTIONThygesen, K.; Alpert, J.; White, H. · Rational Pharmacotherapy in Cardiology · 2008

ANTICOAGULANTS IN ACUTE CORONARY SYNDROMELatfullin, I. A.; Podolskaya, A. A. · Rational Pharmacotherapy in Cardiology · 2009

TOLERABILITY OF VARIOUS ANTIHYPERTENSIVE COMBINATIONSMalchikova, S. V.; Tarlovskaya, E. I. · Rational Pharmacotherapy in Cardiology · 2009